InterCure Ltd.
INCR
$1.60
$0.053.23%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 19.28M | 19.63M | 28.08M | 30.06M | 30.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.28M | 19.63M | 28.08M | 30.06M | 30.27M |
| Cost of Revenue | 14.52M | 14.78M | 19.05M | 18.92M | 17.10M |
| Gross Profit | 4.77M | 4.85M | 9.03M | 11.13M | 13.18M |
| SG&A Expenses | 6.10M | 6.21M | 7.08M | 7.41M | 7.81M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 394.90K | 402.10K | 328.40K | 1.99M | 9.16M |
| Total Operating Expenses | 21.03M | 21.41M | 26.48M | 28.37M | 34.12M |
| Operating Income | -1.74M | -1.77M | 1.60M | 1.68M | -3.85M |
| Income Before Tax | -8.33M | -8.48M | 110.50K | 502.20K | -2.50M |
| Income Tax Expenses | 510.30K | 519.50K | -910.60K | 476.10K | -4.01M |
| Earnings from Continuing Operations | -8.84M | -9.00M | 1.02M | 26.00K | 1.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 38.60K | 39.30K | 317.40K | 34.50K | 941.70K |
| Net Income | -8.80M | -8.96M | 1.34M | 60.60K | 2.45M |
| EBIT | -1.74M | -1.77M | 1.60M | 1.68M | -3.85M |
| EBITDA | -1.21M | -1.27M | 2.47M | 2.58M | -3.81M |
| EPS Basic | -0.20 | -0.20 | 0.03 | 0.00 | 0.05 |
| Normalized Basic EPS | -0.04 | -0.04 | -- | 0.01 | -0.05 |
| EPS Diluted | -0.20 | -0.20 | 0.03 | 0.00 | 0.05 |
| Normalized Diluted EPS | -0.04 | -0.04 | -- | 0.01 | -0.05 |
| Average Basic Shares Outstanding | 44.81M | 44.81M | 49.87M | 42.80M | 45.41M |
| Average Diluted Shares Outstanding | 44.81M | 44.81M | 49.87M | 42.80M | 45.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |